High density lipoprotein physiology: Difference between revisions

Jump to navigation Jump to search
Line 12: Line 12:


====Synthesis and Uptake of Cholesterol====
====Synthesis and Uptake of Cholesterol====
* HDL consists majorly of apo A-I and/or apo A-II.  Both organs synthesize apo A-I while only the liver synthesizes apo A-II.  
* HDL consists majorly of apo A-I and/or apo A-II.  Both organs synthesize apo A-I while only the liver synthesizes apo A-II.  HDL is normally synthesized consisting of  composed mainly of [[phospholipids]] and [[apolipoproteins]].
* Free apo A-I is released into the plasma as nascent HDL.  This readily takes up free cholesterol (FC) from peripheral tissues such as [[fibroblast]]s and [[macrophage]]s mediated by either ATP-binding cassette A1 ([[ABCA1]]), G1/G4, [[Scavenger receptor#Types |scavenger receptor class B type 1 (SR-B1)]], [[Cyp27A1]], caveloin, and [[Passive transport|passive diffusion]], leading to the formation of discoid HDL.
* Free apo A-I is released into the plasma as nascent HDL.  This readily takes up excess free cholesterol (FC) from peripheral tissues such as [[fibroblast]]s and [[macrophage]]s mediated by either ATP-binding cassette A1 ([[ABCA1]]), G1/G4, [[Scavenger receptor#Types |scavenger receptor class B type 1 (SR-B1)]], [[Cyp27A1]], caveloin, and [[Passive transport|passive diffusion]], leading to the formation of discoid HDL.
* Apo A-I activates lecithin:cholesteryl acetyltransferase (LCAT) which catalyses the esterification of the free cholesterol bound to the discoid HDL.
* Apo A-I activates lecithin:cholesteryl acetyltransferase (LCAT) which catalyses the esterification of the free cholesterol bound to the discoid HDL.  The [[Apolipoprotein A1]] acts as a signal protein in mobilizing cholesterol esters from within the cells.


<font color="white">aaaaavvvvvvccccccattttttttttttttttttttttttaaaaaaaaaa</font><font color="red">LCAT</font>                 
<font color="white">aaaaavvvvvvccccccattttttttttttttttttttttttaaaaaaaaaa</font><font color="red">LCAT</font>                 
Line 21: Line 21:


====Maturation and Transfer of Cholesterol====
====Maturation and Transfer of Cholesterol====
* The esterified cholesterol moves into the hydrophobic core of the HDL, changing the HDL particle from discoid to spherical (mature HDL).  This process also prevents the re-uptake of cholesterol by cells.
* The esterified cholesterol moves into the hydrophobic core of the HDL, changing the HDL particle from discoid to spherical (mature HDL).  This process also prevents the re-uptake of cholesterol by cells.  LCAT is responsible for the maturation of HDL particle.
*  The esterified cholesterol can be delivered back to the liver through a number of routes:
*  The esterified cholesterol can be delivered back to the liver through a number of routes:
** By the action of [[cholesterylester transfer protein]] (CETP) - CETP, secreted in the liver, transfers cholesterol from HDL to the apo B–containing lipoproteins e.g., very low-density lipoprotein (VLDL) or intermediate-density lipoprotein (IDL) to be taken up by the liver.  
** By the action of [[cholesterylester transfer protein]] (CETP) - CETP, secreted in the liver, transfers cholesterol from HDL to the apo B–containing lipoproteins e.g., very low-density lipoprotein (VLDL) or intermediate-density lipoprotein (IDL) to be taken up by the liver. Mutations of this transport protein gene causes familial HDL deficiencies and [[Tangier disease]]
** HDL particles may be taken up directly by the liver
** HDL particles may be taken up directly by the liver
** Free cholesterol may be taken up directly by the liver
** Free cholesterol may be taken up directly by the liver
** HDL cholesterol esters may be selectively taken up via the scavenger receptor SR-B1
** HDL cholesterol esters may be selectively taken up via the scavenger receptor SR-B1, which is expressed in the liver.
====Catabolism====
====Catabolism====
* Triglyceride lipases degrade these cholesterol-deplete HDL particles into small, dense HDL which after dissociation, release apo A-I (nascent HDL).  The apo A-1 then either rapidly reuptakes cholesterol again by ABCA1 to discoid HDL or it is endocytosed in the kidney tubule or cleared via glomerular filtration.  These lipoproteins undergo metabolism and subsequent uptake by the liver, primarily by a process mediated by the B,E receptor.
* Triglyceride lipases degrade these cholesterol-deplete HDL particles into small, dense HDL which after dissociation, release apo A-I (nascent HDL).  The apo A-1 then either rapidly reuptakes cholesterol again by ABCA1 to form discoid HDL or it is endocytosed in the kidney tubule or cleared via glomerular filtration.
 
 
* As mentioned above, the HDL is synthesized in liver and intestines as small nascent particles, composed mainly of [[phospholipids]] and [[apolipoproteins]].
* As it travels in the blood it acquires surface components, like more phospholipids, cholesterol and apolipoproteins, from [[triglyceride]] depleted [[chylomicron]]s and remnants of [[VLDL]].
* As this initial HDL particle contains less amounts of cholesterol, it acquires free unesterified cholesterol from tissues of the liver and arterial walls. This hydrophobic free cholesterol sinks into the center of the HDL particle. The [[Apolipoprotein A1]] acts as a signal protein in mobilizing cholesterol esters from within the cells.
* In the peripheral tissues, the nascent HDL particles interact with a cell surface protein called ABCA1 (also known as cholesterol efflux regulatory protein, CERP). High cholesterol levels induce expression of ABCA1 gene and production of the protein. Mutations of this transport protein gene causes familial HDL deficiencies and [[Tangier disease]]. The HDL also accepts cholesterol from triglycerides that has undergone lipolysis.
* Once the cholesterol is acquired by the nascent HDL particles from the peripheral tissues, it gets esterified by a plasma enzyme [[LCAT]] (Lecithin-cholesterol acyltransferase). This enzyme is activated by [[apolipoprotein A1 ]].


==References==
==References==

Revision as of 16:28, 13 September 2013

High Density Lipoprotein Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Physiology

Pathophysiology

Causes

Low HDL
High HDL

Epidemiology and Demographics

Screening

Natural History, Complications and Prognosis

Diagnosis

HDL Laboratory Test

Treatment

Medical Therapy

Prevention

Future or Investigational Therapies

Clinical Trials

Landmark Trials

List of All Trials

Case Studies

Case #1

High density lipoprotein physiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High density lipoprotein physiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High density lipoprotein physiology

CDC on High density lipoprotein physiology

High density lipoprotein physiology in the news

Blogs on High density lipoprotein physiology

Directions to Hospitals Treating High density lipoprotein

Risk calculators and risk factors for High density lipoprotein physiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S [2]

Overview

Physiology

HDL Metabolism

The metabolism of HDL can also be described as the Reverse Cholesterol Transport System. HDL serves a mode of transportation for the excess cholesterol from peripheral tissues to the liver.

Synthesis and Uptake of Cholesterol

  • HDL consists majorly of apo A-I and/or apo A-II. Both organs synthesize apo A-I while only the liver synthesizes apo A-II. HDL is normally synthesized consisting of composed mainly of phospholipids and apolipoproteins.
  • Free apo A-I is released into the plasma as nascent HDL. This readily takes up excess free cholesterol (FC) from peripheral tissues such as fibroblasts and macrophages mediated by either ATP-binding cassette A1 (ABCA1), G1/G4, scavenger receptor class B type 1 (SR-B1), Cyp27A1, caveloin, and passive diffusion, leading to the formation of discoid HDL.
  • Apo A-I activates lecithin:cholesteryl acetyltransferase (LCAT) which catalyses the esterification of the free cholesterol bound to the discoid HDL. The Apolipoprotein A1 acts as a signal protein in mobilizing cholesterol esters from within the cells.

aaaaavvvvvvccccccattttttttttttttttttttttttaaaaaaaaaaLCAT

aaaaavvvvvvaaaaaaaaaaaLecithin + Cholesterol ———-> Lysolecithin + Cholesterol ester

Maturation and Transfer of Cholesterol

  • The esterified cholesterol moves into the hydrophobic core of the HDL, changing the HDL particle from discoid to spherical (mature HDL). This process also prevents the re-uptake of cholesterol by cells. LCAT is responsible for the maturation of HDL particle.
  • The esterified cholesterol can be delivered back to the liver through a number of routes:
    • By the action of cholesterylester transfer protein (CETP) - CETP, secreted in the liver, transfers cholesterol from HDL to the apo B–containing lipoproteins e.g., very low-density lipoprotein (VLDL) or intermediate-density lipoprotein (IDL) to be taken up by the liver. Mutations of this transport protein gene causes familial HDL deficiencies and Tangier disease
    • HDL particles may be taken up directly by the liver
    • Free cholesterol may be taken up directly by the liver
    • HDL cholesterol esters may be selectively taken up via the scavenger receptor SR-B1, which is expressed in the liver.

Catabolism

  • Triglyceride lipases degrade these cholesterol-deplete HDL particles into small, dense HDL which after dissociation, release apo A-I (nascent HDL). The apo A-1 then either rapidly reuptakes cholesterol again by ABCA1 to form discoid HDL or it is endocytosed in the kidney tubule or cleared via glomerular filtration.

References


Template:WikiDoc Sources